2151-4658/asset/olbannerleft.gif?v=1&s=75d1dd4933b4687fdb365bb32190b0a4ef453ee7)
2151-4658/asset/olbannerright.gif?v=1&s=a36ba6af41bd9af370864f6461a516746a709d31)
Original Article
You have full text access to this OnlineOpen article
Glucocorticoid therapy in giant cell arteritis: Duration and adverse outcomes
Article first published online: 7 OCT 2003
DOI: 10.1002/art.11388
Copyright © 2003 by the American College of Rheumatology
1529-0131a/asset/cover.gif?v=1&s=4b71f39689e424fbb0e6725b1c033cc646a4272b "Arthritis Care & Research")
Additional Information
How to Cite
Proven, A., Gabriel, S. E., Orces, C., O'Fallon, W. M. and Hunder, G. G. (2003), Glucocorticoid therapy in giant cell arteritis: Duration and adverse outcomes. Arthritis & Rheumatism, 49: 703–708. doi: 10.1002/art.11388
Publication History
- Issue published online: 7 OCT 2003
- Article first published online: 7 OCT 2003
- Manuscript Accepted: 28 AUG 2002
- Manuscript Received: 13 MAY 2002
- Abstract
- Article
- References
- Cited By
Cited in:
- CrossRef
This article has been cited by:
- 1, , Biologic treatment of large-vessel vasculitides, Current Opinion in Rheumatology, 2012, 24, 1, 31
- 2, , Giant cell arteritis: A review of classification, pathophysiology, geoepidemiology and treatment, Autoimmunity Reviews, 2012, 11, 6-7, A544
- 3, , Incidence of infections in patients with giant cell arteritis: A cohort study, Arthritis Care & Research, 2012, 64, 4Direct Link:
- 4
- 5, Approche thérapeutique de la vascularite à cellules géantes (Maladie de Horton), Revue du Rhumatisme, 2011, 78, A15
- 6, , , Evidencias sobre la eficacia de los tratamientos biológicos en las vasculitis sistémicas, Seminarios de la Fundación Española de ReumatologÃa, 2011, 12, 3, 73
- 7, , , , , , Incidence and US Costs of Corticosteroid-Associated Adverse Events: A Systematic Literature Review, Clinical Therapeutics, 2011, 33, 10, 1413
- 8, , , , , , , , , , , Ischaemic manifestations in giant cell arteritis are associated with area level socio-economic deprivation, but not cardiovascular risk factors, Rheumatology, 2011, 50, 11, 2014
- 9, , , , , Jaw Dropping: The Necessity of a History and a Biopsy in Suspected Temporal Arteritis, Neuro-Ophthalmology, 2011, 35, 3, 156
- 10, , , , , New indications for biological therapies, Internal and Emergency Medicine, 2011, 6, S1, 1
- 11, , , Pneumocystis jiroveci pneumonia in giant cell arteritis: A case series, Arthritis Care & Research, 2011, 63, 5Direct Link:
- 12, , Polymyalgia Rheumatica and Giant Cell Arteritis in Older Patients, Drugs & Aging, 2011, 28, 8, 651
- 13, , , , , Polymyalgia rheumatica and giant cell arteritis: management of two diseases of the elderly, Aging Health, 2011, 7, 4, 633
- 14, , Recent Advances in Diagnostic Strategies for Giant Cell Arteritis, Current Neurology and Neuroscience Reports, 2011, 12, 2, 138
- 15, , , , , , , , , , Relapses and Recurrences in Giant Cell Arteritis, Medicine, 2011, 90, 3, 186
- 16
- 17, , , , , , , , , , Tissue and serum markers of inflammation during the follow-up of patients with giant-cell arteritis--a prospective longitudinal study, Rheumatology, 2011, 50, 11, 2061
- 18
- 19
- 20
- 21, , , , , , , , Clinical relevance of persistently elevated circulating cytokines (tumor necrosis factor α and interleukin-6) in the long-term followup of patients with giant cell arteritis, Arthritis Care & Research, 2010, 62, 6Direct Link:
- 22, , , Current understanding and management of giant cell arteritis and polymyalgia rheumatica, Expert Review of Clinical Immunology, 2010, 6, 6, 913
- 23, , Diagnosis and management of giant cell arteritis: a review, Current Opinion in Ophthalmology, 2010, 21, 6, 417
- 24, , En la arteritis de la temporal: controversias terapéuticas, NeurologÃa, 2010, 25, 7, 453
- 25
- 26, , , , , , , , Incidence of herpes zoster in patients with giant cell arteritis: a population-based cohort study, Rheumatology, 2010, 49, 11, 2104
- 27, , Temporal Arteritis: Treatment Controversies, NeurologÃa (English Edition), 2010, 25, 7, 453
- 28, , , , , , The Rochester Epidemiology Project: exploiting the capabilities for population-based research in rheumatic diseases, Rheumatology, 2010, 50, 1, 6
- 29, , , , , , Aktuelle Therapieansätze bei Riesenzellarteriitis, Zeitschrift für Rheumatologie, 2009, 68, 2, 132
- 30, , , Cardiovascular involvement in primary systemic vasculitis, Best Practice & Research Clinical Rheumatology, 2009, 23, 3, 419
- 31, , , Current advancements in the management of giant cell arteritis, Aging Health, 2009, 5, 4, 519
- 32, , , , Delayed Diagnosis of Biopsy-Negative Giant Cell Arteritis Presenting as Fever of Unknown Origin, Journal of General Internal Medicine, 2009, 24, 4, 532
- 33
- 34, , Giant cell arteritis: an updated review, Acta Ophthalmologica, 2009, 87, 1Direct Link:
- 35, , , , , Increased Angiotensin II Type 1 Receptor Expression in Temporal Arteries from Patients with Giant Cell Arteritis, Ophthalmology, 2009, 116, 5, 990
- 36, , Internistische und serologische Befunde der Riesenzellarteriitis, Zeitschrift für Rheumatologie, 2009, 68, 2, 124
- 37, , Polymyalgica rheumatica and giant cell arteritis, Reviews in Clinical Gerontology, 2009, 18, 02, 91
- 38, , Pulmonale infektiöse Komplikationen rheumatischer Erkrankungen, Zeitschrift für Rheumatologie, 2009, 68, 8, 658
- 39, , Treatment and outcomes of large vessel arteritis, Best Practice & Research Clinical Rheumatology, 2009, 23, 3, 325
- 40, , , , Vasculitis working group: Selected unanswered questions related to giant cell arteritis and anti-neutrophil cytoplasmic antibody-associated vasculitis, Joint Bone Spine, 2009, 76, 4, 440
- 41, , , Empfehlungen der European League Against Rheumatism (EULAR) zur Behandlung von „Großgefäßvaskulitiden“, Zeitschrift für Rheumatologie, 2008, 68, 3, 260
- 42, , , , , Giant cell arteritis and polymyalgia rheumatica: Role of cytokines in the pathogenesis and implications for treatment, Cytokine, 2008, 44, 2, 207
- 43, , Improving therapeutic options for patients with giant cell arteritis, Current Opinion in Rheumatology, 2008, 20, 1, 17
- 44, , , , , Intraoperative Predictability of Temporal Artery Biopsy Results, Ophthalmic Plastic & Reconstructive Surgery, 2008, 24, 5, 372
- 45, , , Neuro-ophthalmic complications in giant cell arteritis, Current Allergy and Asthma Reports, 2008, 8, 4, 323
- 46
- 47
- 48
- 49, , Temporal arteritis in Hong Kong, International Journal of Rheumatic Diseases, 2008, 11, 2Direct Link:
- 50, , , , , , The Clinical Utility of High Resolution Magnetic Resonance Imaging in the Diagnosis of Giant Cell Arteritis, The Neurologist, 2008, 14, 5, 330
- 51
- 52, , , , , , , Adjunctive methotrexate for treatment of giant cell arteritis: An individual patient data meta-analysis, Arthritis & Rheumatism, 2007, 56, 8Direct Link:
- 53, , , , , Five Clinical Conundrums in the Management of Giant Cell Arteritis, Rheumatic Disease Clinics of North America, 2007, 33, 4, 819
- 54
- 55, Induktionstherapie mit Kortikoidpulsen zur Behandlung der Arteriitis temporalis, Zeitschrift für Rheumatologie, 2007, 66, 2, 165
- 56, , , Update on the use of biologics in primary systemic vasculitides, Expert Review of Clinical Immunology, 2007, 3, 6, 901
- 57, , , Giant cell arteritis, Clinical & Experimental Ophthalmology, 2006, 34, 2Direct Link:
- 58, , , , , , , , , Population-based assessment of adverse events associated with long-term glucocorticoid use, Arthritis Care & Research, 2006, 55, 3Direct Link:
- 59, , , , , , Repetitive 18F-fluorodeoxyglucose positron emission tomography in giant cell arteritis: A prospective study of 35 patients, Arthritis Care & Research, 2006, 55, 1Direct Link:
- 60, , Therapy for giant cell arteritis: Can we do better?, Arthritis & Rheumatism, 2006, 54, 10Direct Link:
- 61, , , , , , , , , Treatment of giant cell arteritis using induction therapy with high-dose glucocorticoids: A double-blind, placebo-controlled, randomized prospective clinical trial, Arthritis & Rheumatism, 2006, 54, 10Direct Link:
- 62, , , Are steroids alone sufficient for the treatment of giant cell arteritis?, Best Practice & Research Clinical Rheumatology, 2005, 19, 2, 277
- 63, , , Glucocorticoide: Stellenwert in der Therapie der Vaskulitis, Zeitschrift für Rheumatologie, 2005, 64, 3, 155
- 64, , , , , , , , , , Longitudinal patterns in the prevention of osteoporosis in glucocorticoid-treated patients, Arthritis & Rheumatism, 2005, 52, 8Direct Link:
- 65, , , , , , , , , Silent versus cranial giant cell arteritis. Initial presentation and outcome of 50 biopsy-proven cases, European Journal of Internal Medicine, 2005, 16, 3, 183
- 66, , , , , Initiation of Glucocorticoid Therapy: Before or After Temporal Artery Biopsy?, Mayo Clinic Proceedings, 2004, 79, 4, 483
- 67, , La maladie de Horton compliquée : modalités thérapeutiques, La Presse Médicale, 2004, 33, 1, 51
- 68, , La maladie de Horton simple : modalités thérapeutiques, La Presse Médicale, 2004, 33, 1, 41
- 69, Qu'a-t-on appris sur la maladie de Horton depuis dix ans ?, La Revue de Médecine Interne, 2004, 25, 11, 816